https://doi.org/10.4081/cc.2024.15777
Manual trigger point treatment in migraine management: a scope review
Submitted: 16 September 2024
Accepted: 7 November 2024
Published: 12 December 2024
Accepted: 7 November 2024
Abstract Views: 48
PDF: 11
SUPPLEMENTARY: 2
SUPPLEMENTARY: 2
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Background: Migraine is a debilitating neurological disorder that significantly impacts the quality of life of millions worldwide. Traditional pharmacological treatments sometimes fall short due to side effects and inconsistent efficacy, prompting a surge of interest in complementary therapies. Among these, manual trigger point therapy emerges as a promising approach.
Methods: This comprehensive scoping review analyzes data from five studies with Pedro scores ranging from 4/11 to 7/11 and RoB 2, each assessing the impact of manual trigger point therapy on migraine management.
Results: The review reveals that manual trigger point therapy may reduce the frequency and severity of migraine, enhancing overall patient well-being. Some studies suggest that trigger point therapy alone may suffice as an effective standalone treatment. Notably, this therapeutic approach increases effectiveness of concomitant conventional treatments, offering a potential breakthrough in holistic migraine care.
Conclusions: While present evidence supports the integration of manual trigger point therapy into migraine management protocols, the varying quality of the studies highlights an urgent need for additional investigation with standardized methodologies and rigorous blinding to validate these promising early findings.
1. Awaki E, Takeshima T, Matsumori Y, Hirata K, Miyazaki N, Takemura R, et al. Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) Study. Neurol Ther 2024;13:165–82.
DOI: https://doi.org/10.1007/s40120-023-00569-3
2. Shapiro RE, Nicholson RA, Seng EK, Buse DC, Reed ML, Zagar AJ, et al. Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life. Neurology 2024;102:e208074.
DOI: https://doi.org/10.1212/WNL.0000000000208074
3. Tedeschi R, Pillastrini P, Pierangeli G, Favoni V, Cortelli P, Cevoli S. Is physiotherapy in migraines known to sufferers? A cross-sectional study. Neurol Sci 2023.
DOI: https://doi.org/10.1007/s10072-023-07195-9
4. Ashina M, Lipton RB, Ailani J, Versijpt J, Sacco S, Mitsikostas DD, et al. Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial. Eur J Neurol 2024;31:e16131.
DOI: https://doi.org/10.1111/ene.16131
5. de Vries Lentsch S, van der Arend BWH, de Boer I, van Zwet EW, MaassenVanDenBrink A, Terwindt GM. Depression and treatment with anti-calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine. Eur J Neurol 2024;31:e16106.
DOI: https://doi.org/10.1111/ene.16106
6. Alsaadi T, Kayed DM, Al-Madani A, Hassan AM, Krieger D, Riachi N, et al. Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE). Neurol Ther 2024.
DOI: https://doi.org/10.1007/s40120-023-00576-4
7. Ghanbari A, Askarzadeh S, Petramfar P, Mohamadi M. Migraine responds better to a combination of medical therapy and trigger point management than routine medical therapy alone. NeuroRehabilitation 2015;37:157–63.
DOI: https://doi.org/10.3233/NRE-151248
8. Bevilaqua-Grossi D, Gonçalves MC, Carvalho GF, Florencio LL, Dach F, Speciali JG, Bigal ME, Chaves TC. Additional Effects of a Physical Therapy Protocol on Headache Frequency, Pressure Pain Threshold, and Improvement Perception in Patients With Migraine and Associated Neck Pain: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2016;97:866-74.
DOI: https://doi.org/10.1016/j.apmr.2015.12.006
9. Yedikardachian D, Quasthoff S, Lechner AT, Giuliani A, Fazekas F. [Migraine prophylaxis with trigger point therapy and lymphatic drainage: A pilot study]. Wien Med Wochenschr 2017;167:359–67.
DOI: https://doi.org/10.1007/s10354-017-0588-9
10. Gandolfi M, Geroin C, Valè N, Marchioretto F, Turrina A, Dimitrova E, et al. Does myofascial and trigger point treatment reduce pain and analgesic intake in patients undergoing onabotulinumtoxinA injection due to chronic intractable migraine? Eur J Phys Rehabil Med 2018;54:1–12.
DOI: https://doi.org/10.23736/S1973-9087.17.04568-3
11. Espí-López GV, Ruescas-Nicolau MA, Nova-Redondo C, Benítez-Martínez JC, Dugailly PM, Falla D. Effect of Soft Tissue Techniques on Headache Impact, Disability, and Quality of Life in Migraine Sufferers: A Pilot Study. J Altern Complement Med 2018;24:1099–107.
DOI: https://doi.org/10.1089/acm.2018.0048
12. Tedeschi R. Unveiling the Potential of Trigger Point Therapy: Exploring its Efficacy in Managing Muscular Spasticity - A Scoping Review. Muscles, Ligaments and Tendons Journal 2023;13:564–73.
DOI: https://doi.org/10.32098/mltj.04.2023.07
13. Liu L, Huang QM, Liu QG. In vitro culture of muscle cells derived from myofascial trigger points. Acupunct Med 2024;42:39–43.
DOI: https://doi.org/10.1177/09645284231207872
14. Perreault T, Arendt-Nielson L, Fernández-de-Las-Peñas C, Dommerholt J, Herrero P, Hubbard R. Intramuscular Electrical Stimulation for the Treatment of Trigger Points in Patients with Chronic Migraine: A Protocol for a Pilot Study Using a Single-Case Experimental Design. Medicina (Kaunas) 2023;59:1380.
DOI: https://doi.org/10.3390/medicina59081380
15. Tedeschi R. An overview and critical analysis of the Graston technique for foot-related conditions: a scoping review. Manuelle Medizin 2024.
DOI: https://doi.org/10.1007/s00337-023-01018-w
16. Di Antonio S, Arendt-Nielsen L, Ponzano M, Bovis F, Torelli P, Finocchi C, Castaldo M. Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients. Cephalalgia 2022;42:827-45.
DOI: https://doi.org/10.1177/03331024221082506
17. Peters: Joanna Briggs Institute Reviewer’s Manual, JBI - Google Scholar [Internet]. [cited 2022 Jun 9]. Available from: https://scholar-google-com.ezproxy.unibo.it/scholar_lookup?hl=en&publication_year=2020&author=MDJ+Peters&author=C+Godfrey&author=P+McInerney&author=Z+Munn&author=AC+Tricco&author=H+Khalil&title=Joanna+Briggs+Institute+Reviewer%27s+Manual%2C+JBI.
18. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med 2018;169:467–73.
DOI: https://doi.org/10.7326/M18-0850
19. Zhang B, Xi Y, Huang Y, Zhang Y, Guo F, Yang H. Integration of single-nucleus RNA sequencing and network disturbance to elucidate crosstalk between multicomponent drugs and trigeminal ganglia cells in migraine. J Ethnopharmacol 2024;319:117286.
DOI: https://doi.org/10.1016/j.jep.2023.117286
20. Pietramaggiori G, Bastin A, Ricci F, Bassetto F, Scherer S. Minimally invasive nerve and artery sparing surgical approach for temporal migraines. JPRAS Open 2024;39:32–41.
DOI: https://doi.org/10.1016/j.jpra.2023.11.005
21. Smirnoff L, Pham K. A Role for Visual Art Therapy in the Management of Migraine. Curr Pain Headache Rep 2024.
DOI: https://doi.org/10.1007/s11916-023-01207-1
22. Schrepf A, Maixner W, Fillingim R, Veasley C, Ohrbach R, Smith S, et al. The Chronic Overlapping Pain Condition Screener. J Pain 2024;25:265–72.
DOI: https://doi.org/10.1016/j.jpain.2023.08.009
23. Turolla A, Guccione AA, Tedeschi R, Pillastrini P. Is Clinical Research as Helpful to Clinicians as It Could Be? Physical Therapy 2023;103.
DOI: https://doi.org/10.1093/ptj/pzad060
24. Tedeschi R, Giorgi F. What is known about the RegentK regenerative treatment for ruptured anterior cruciate ligament? A scoping review. Manuelle Medizin 2023;61:181–7.
DOI: https://doi.org/10.1007/s00337-023-00953-y
25. Tedeschi R. Can beneficial frequencies in physiotherapy help treatment? Scoping Review. Rwanda Medical Journal 2023;80:88–94.
DOI: https://doi.org/10.4314/rmj.v80i2.8
How to Cite
1.
Tedeschi R. Manual trigger point treatment in migraine management: a scope review. Confinia Cephalal [Internet]. 2024 Dec. 12 [cited 2024 Dec. 22];34(2). Available from: https://www.confiniacephalalgica.com/site/article/view/15777
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Sarah Cargnin, Salvatore Terrazzino, Ennio Pucci, Michele Viana, Drug resistance to triptans: a problem for thousands of people in Italy , Confinia Cephalalgica: Vol. 26 No. 1 (2016)
- Michele Viana, Giuseppe Nappi, Cyclic migraine. From pathophysiological understanding to therapeutic opportunities in patients with migraine attacks showing predictable periodicity , Confinia Cephalalgica: Vol. 26 No. 1 (2016)
- Michele Corrado, Elena Mazzotta, Gloria Vaghi, Francescantonio Cammarota, Federico Bighiani, Alessandro Antoniazzi, Daniele Martinelli, Maria Magdalena Pocora, Luca Martinis, Valentina Grillo, Sara Bottiroli, Armando Perrotta, Giuseppe Cosentino, Grazia Sances, Cristina Tassorelli, Roberto De Icco, Normative values of the nociceptive blink reflex habituation , Confinia Cephalalgica: Vol. 34 No. 1 (2024)
- Chiara Rosignoli, Agnese Onofri, Federico De Santis, Simona Sacco, Raffaele Ornello, Efficacy and safety of greater occipital nerve block with a small volume of lidocaine and methylprednisolone in tertiary headache center , Confinia Cephalalgica: Vol. 34 No. 2 (2024)
- Simona Guerzoni, Flavia Lo Castro, Carlo Baraldi, Daria Brovia, Fabio Tascedda, Veronica Rivi, Luca Pani, Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache , Confinia Cephalalgica: Vol. 34 No. 1 (2024)
- Elisa Rubino, Fausto Roveta, Andrea Marcinnò, Fabio Ferrandes, Elisa Maria Piella, Innocenzo Rainero, Intravenous methylprednisolone in patients with episodic cluster headache non-responders to oral steroids: results from an observational, interventional, single-center study , Confinia Cephalalgica: Vol. 34 No. 1 (2024)
- Marina Romozzi, Andrea Burgalassi, Catello Vollono, Maria Albanese, Giulia Vigani, Francesco De Cesaris, Alberto Chiarugi, Paolo Calabresi, Luigi Francesco Iannone, Prospective evaluation of aura during anti-calcitonin gene-related peptide monoclonal antibody therapy after 52 weeks of treatment , Confinia Cephalalgica: Vol. 34 No. 1 (2024)
- Giulia Paparella, Chiara Abbatantuono, Livio Clemente, Stefania Scannicchio, Marina de Tommaso, Cognitive reserve and well-being in migraine patients: a multidimensional approach to migraine assessment in an Italian tertiary headache center , Confinia Cephalalgica: Vol. 34 No. 1 (2024)
- Marta Allena, Michele Viana, Abstracts di interesse cefalalgico , Confinia Cephalalgica: Vol. 26 No. 1 (2016)
- Selene Attorre, Andrea Burgalassi, Giulia Vigani, Francesco De Cesaris, Marina Romozzi, Luigi Francesco Iannone, Sex and gender differences in the epidemiology, clinical features, and pathophysiology of trigeminal autonomic cephalalgias , Confinia Cephalalgica: Vol. 34 No. 2 (2024)
You may also start an advanced similarity search for this article.
